Status:

ACTIVE_NOT_RECRUITING

Safety and Performance of the Biphasic Plate Distal Femur: A Multicenter Case Series

Lead Sponsor:

41medical AG

Collaborating Sponsors:

AO Innovation Translation Center

Conditions:

Distal Femur Fracture

Periprosthetic Fractures

Eligibility:

All Genders

18+ years

Brief Summary

The goal of this observational multicenter case series is to assess the safety and performance of the CE-marked "Biphasic Plate Distal Femur" during standard of care.

Detailed Description

The goal of this observational study is to assess the safety and performance of the CE-marked "Biphasic Plate Distal Femur" during standard of care. The study is conducted as a retrospective and prosp...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Patients with fractures of the distal femur requiring internal fixation and treated with the Biphasic Plate DF as indicated according to the IFU. As per the IFU, the Biphasic Plate DF is indicated for:
  • Distal shaft fractures
  • Supracondylar fractures
  • Intraarticular fractures
  • Periprosthetic fractures
  • No other major implant beside the Biphasic Plate DF is used for fixation of the distal femur fracture, with the exceptions of lag screw(s) and/or cerclage wire(s), and/or a joint replacement.
  • Patients who are willing and able to comply with postoperative FUs per local standard of care.
  • Ability to provide informed consent according to the IRB/EC defined and approved procedures.
  • Patients over 18 years of age
  • Exclusion Criteria (preoperatively):
  • Patient is participating in another interventional clinical trial.
  • Exclusion Criteria (intraoperatively):
  • Change of surgical plan intraoperatively at the discretion of the surgeon that Biphasic Plate DF is not used
  • Necessity to apply a second (medial) plate (double plating) or an intramedullary nail in case of critical fixation distally

Exclusion

    Key Trial Info

    Start Date :

    February 29 2024

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    October 31 2027

    Estimated Enrollment :

    60 Patients enrolled

    Trial Details

    Trial ID

    NCT06028971

    Start Date

    February 29 2024

    End Date

    October 31 2027

    Last Update

    July 10 2025

    Active Locations (5)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 2 (5 locations)

    1

    Univeritätsklinikum Münster

    Münster, North Rhine-Westphalia, Germany, 48149

    2

    Diakonie Jung-Stilling Siegen

    Siegen, North Rhine-Westphalia, Germany, 57074

    3

    Universitätsspital Zürich

    Zurich, Canton of Zurich, Switzerland, 8091

    4

    Kantonsspital Graubünden

    Chur, Kanton Graubünden, Switzerland, 7000